|
IMNM Immunome Inc 1472012 |
| Balance Sheet |
|
Current Assets
|
244,040,000 |
|
Assets
|
256,898,000 |
|
Current Liabilities
|
39,528,000 |
|
Liabilities
|
41,992,000 |
|
Equity
|
214,906,000 |
|
Shares Out
|
60,054,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-68,734,000 |
|
Investing Cash Flow
|
-94,821,000 |
| Market Analysis |
Market Cap
|
916,429,699 |
|
Price
|
8.56 |
|
BVPS
|
3.58 |
|
PB
|
2.39 |
|
EPS
|
-5.64 |
|
PS
|
78.73 |
|
FCF
|
-163,555,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IMNM documents filed with the SEC.
IMNM Filings
Clear
